Inbunden, Engelska, 2027
1 704 kr
Kommande
Authoritative reference on Feng ligands for high-enantioselectivity asymmetric transformations Chiral N,N'-Dioxide Amides in Asymmetric Catalysis: A New Class of Privileged Ligands and Catalysts provides a systematic account of these ligands, often called Feng ligands, which frequently outperform other chiral ligands in enantioselectivity, substrate scope, and stereocontrol. This reference traces two decades of development across Lewis acid catalysis, organocatalysis, bimetallic relay catalysis, and photocatalysis. The book covers the historical evolution of chiral N,N'-dioxide amides, their detailed coordination chemistry with various metals, and applications across nucleophilic addition, oxidation, reduction, pericyclic reactions, and radical reactions. Mechanistic insights into catalytic processes facilitated by N,N'-dioxide-metal complexes are presented alongside illustrated examples and comparisons with classic catalysts, enabling readers to select appropriate asymmetric catalysts for producing target chiral molecules. Readers will also find: Complete coverage of the structural aspects and conformational flexibility that give N,N'-dioxide amides their privileged status among chiral ligandsDetailed treatment of organocatalytic applications of chiral N,N'-dioxide amides in asymmetric synthesis with illustrated reaction examplesMechanistic analysis of catalytic processes facilitated by N,N'-dioxide-metal complexes, clarifying stereocontrol in key transformationsApplications in bioactive compound synthesis and chiral drug development relevant to pharmaceutical research and industrial process chemistrySystematic comparisons with established chiral catalyst systems, providing context for ligand selection in enantioselective reaction designDesigned for organic, catalytic, and medicinal chemists in both academic and industrial settings, this book serves as a definitive resource on N,N'-dioxide amide ligand design and application. Researchers in organometallic, inorganic, and pharmaceutical chemistry will find the mechanistic insights and reaction coverage directly applicable to advancing enantioselective synthesis.